339 related articles for article (PubMed ID: 26405700)
21. Presenting features and disease course of pediatric ulcerative colitis.
Aloi M; D'Arcangelo G; Pofi F; Vassallo F; Rizzo V; Nuti F; Di Nardo G; Pierdomenico M; Viola F; Cucchiara S
J Crohns Colitis; 2013 Dec; 7(11):e509-15. PubMed ID: 23583691
[TBL] [Abstract][Full Text] [Related]
22. Colectomy is a risk factor for venous thromboembolism in ulcerative colitis.
Kaplan GG; Lim A; Seow CH; Moran GW; Ghosh S; Leung Y; Debruyn J; Nguyen GC; Hubbard J; Panaccione R
World J Gastroenterol; 2015 Jan; 21(4):1251-60. PubMed ID: 25632199
[TBL] [Abstract][Full Text] [Related]
23. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease.
Romberg-Camps MJ; Dagnelie PC; Kester AD; Hesselink-van de Kruijs MA; Cilissen M; Engels LG; Van Deursen C; Hameeteman WH; Wolters FL; Russel MG; Stockbrügger RW
Am J Gastroenterol; 2009 Feb; 104(2):371-83. PubMed ID: 19174787
[TBL] [Abstract][Full Text] [Related]
24. Incidence, outcomes, and health services burden of very early onset inflammatory bowel disease.
Benchimol EI; Mack DR; Nguyen GC; Snapper SB; Li W; Mojaverian N; Quach P; Muise AM
Gastroenterology; 2014 Oct; 147(4):803-813.e7; quiz e14-5. PubMed ID: 24951840
[TBL] [Abstract][Full Text] [Related]
25. Baseline risk assessment of patients with ulcerative colitis: does initial treatment selection influence outcomes?
Mosli M; Alfaer S; Almalaki T; Albeshry A; Aljehani S; Alshmrani B; Habib Z; Jawa H; Qari Y
Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):80-85. PubMed ID: 30199472
[TBL] [Abstract][Full Text] [Related]
26. Elderly-Onset and Adult-Onset Ulcerative Colitis Are More Similar than Previously Reported in a Nationwide Cohort.
Kumar V; Shah Y; Patel D; Khan N
Dig Dis Sci; 2017 Oct; 62(10):2857-2862. PubMed ID: 28884254
[TBL] [Abstract][Full Text] [Related]
27. Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009.
Lakatos PL; Golovics PA; David G; Pandur T; Erdelyi Z; Horvath A; Mester G; Balogh M; Szipocs I; Molnar C; Komaromi E; Veres G; Lovasz BD; Szathmari M; Kiss LS; Lakatos L
Am J Gastroenterol; 2012 Apr; 107(4):579-88. PubMed ID: 22233693
[TBL] [Abstract][Full Text] [Related]
28. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study).
Solberg IC; Lygren I; Jahnsen J; Aadland E; Høie O; Cvancarova M; Bernklev T; Henriksen M; Sauar J; Vatn MH; Moum B;
Scand J Gastroenterol; 2009; 44(4):431-40. PubMed ID: 19101844
[TBL] [Abstract][Full Text] [Related]
29. Low colectomy rate five years after diagnosis of ulcerative colitis. Results from a prospective population-based cohort in Sweden (ICURE) diagnosed during 2005-2009.
Rönnblom A; Holmström T; Tanghöj H; Karlbom U; Thörn M; Sjöberg D
Scand J Gastroenterol; 2016 Nov; 51(11):1339-44. PubMed ID: 27356846
[TBL] [Abstract][Full Text] [Related]
30. Is current smoking still an important environmental factor in inflammatory bowel diseases? Results from a population-based incident cohort.
Lakatos PL; Vegh Z; Lovasz BD; David G; Pandur T; Erdelyi Z; Szita I; Mester G; Balogh M; Szipocs I; Molnar C; Komaromi E; Golovics PA; Mandel M; Horvath A; Szathmari M; Kiss LS; Lakatos L
Inflamm Bowel Dis; 2013 Apr; 19(5):1010-7. PubMed ID: 23399739
[TBL] [Abstract][Full Text] [Related]
31. Systematic analysis of annual health resource utilization and costs in hospitalized patients with inflammatory bowel disease in Switzerland.
Schoepfer A; Vavricka SR; Brüngger B; Reich O; Blozik E; Bähler C
Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):868-875. PubMed ID: 29757772
[TBL] [Abstract][Full Text] [Related]
32. Similar clinical characteristics of familial and sporadic inflammatory bowel disease in South Korea.
Chung SH; Park SJ; Lee HS; Hong SP; Cheon JH; Kim TI; Kim WH
World J Gastroenterol; 2014 Dec; 20(45):17120-6. PubMed ID: 25493025
[TBL] [Abstract][Full Text] [Related]
33. Two-year delay in ulcerative colitis diagnosis is associated with anti-tumor necrosis factor alpha use.
Kang HS; Koo JS; Lee KM; Kim DB; Lee JM; Kim YJ; Yoon H; Jang HJ
World J Gastroenterol; 2019 Feb; 25(8):989-1001. PubMed ID: 30833804
[TBL] [Abstract][Full Text] [Related]
34. Predictors of Hospital Readmissions for Ulcerative Colitis in the United States: A National Database Study.
Poojary P; Saha A; Chauhan K; Simoes P; Sands BE; Cho J; Ullman T; Nadkarni G; Ungaro R
Inflamm Bowel Dis; 2017 Mar; 23(3):347-356. PubMed ID: 28221246
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for ulcerative colitis-associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: results of a population-based study.
Lakatos L; Mester G; Erdelyi Z; David G; Pandur T; Balogh M; Fischer S; Vargha P; Lakatos PL
Inflamm Bowel Dis; 2006 Mar; 12(3):205-11. PubMed ID: 16534422
[TBL] [Abstract][Full Text] [Related]
36. Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.
Cassinotti A; Actis GC; Duca P; Massari A; Colombo E; Gai E; Annese V; D'Albasio G; Manes G; Travis S; Porro GB; Ardizzone S
Am J Gastroenterol; 2009 Nov; 104(11):2760-7. PubMed ID: 19623172
[TBL] [Abstract][Full Text] [Related]
37. Significance of serological markers in the disease course of ulcerative colitis in a prospective clinical cohort of patients.
Kovacs G; Sipeki N; Suga B; Tornai T; Fechner K; Norman GL; Shums Z; Antal-Szalmas P; Papp M
PLoS One; 2018; 13(3):e0194166. PubMed ID: 29590158
[TBL] [Abstract][Full Text] [Related]
38. The Demographic and Clinical Characteristics of Ulcerative Colitis in a Northeast Brazilian Population.
da Silva BC; Lyra AC; Mendes CM; Ribeiro CP; Lisboa SR; de Souza MT; Portela RC; Santana GO
Biomed Res Int; 2015; 2015():359130. PubMed ID: 26509150
[TBL] [Abstract][Full Text] [Related]
39. Outcome of Ulcerative Colitis 20 Years after Diagnosis in a Prospective Population-based Inception Cohort from South-Eastern Norway, the IBSEN Study.
Monstad IL; Solberg IC; Cvancarova M; Hovde O; Henriksen M; Huppertz-Hauss G; Gunther E; Moum BA; Stray N; Vatn M; Hoie O; Jahnsen J
J Crohns Colitis; 2021 Jun; 15(6):969-979. PubMed ID: 33367569
[TBL] [Abstract][Full Text] [Related]
40. Serological markers associated with disease behavior and response to anti-tumor necrosis factor therapy in ulcerative colitis.
Kevans D; Waterman M; Milgrom R; Xu W; Van Assche G; Silverberg M
J Gastroenterol Hepatol; 2015 Jan; 30(1):64-70. PubMed ID: 25041458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
